Offering a critical analysis of Canada’s access and reimbursement environment, and in-depth discussions on how to adapt market access strategies — especially at a time when affordability and overall health system sustainability are top of mind.

Speaker Name

Alexis Sciuk

Canadian Health Care Solutions Lead

Speaker Name

Farah Husein

Director, Evidence Generation
Scientific and Medical Affairs, Takeda Canada

Featured Speakers
Speaker Name

Dr. Mark Chilvers

Pediatric Respirologist, BCCH CF Clinic Director, Medical Director
CF Care BC

Speaker Name

Sang Mi Lee

Access Lead, Personalized Healthcare

Speaker Name

Brad Groves

Associate Director, Managed Access

This Year’s Highlights
  • The impact of the pandemic on CADTH reviews and pCPA negotiations, and how to mitigate time-to-market delays
  • Cell and Gene Therapy: How to secure public/private payer reimbursement for these potentially life-changing but high-cost therapies
  • How to attract and retain top-notch talent to Canada’s life sciences sector amid shifting public policy
  • Data and AI: How to obtain, analyze, and utilize health outcome data to empower decision-making from clinical trials to reimbursement and beyond

Practitioners at every level with experience in:

  • Pricing
  • Reimbursement
  • Market access
  • Patient access
  • Government and regulatory affairs
  • Health economics
  • Research and development
  • Policy and compliance
  • Pharmacy services
  • Marketing
  • National trade
  • Formularies
  • Business development
  • Sales

From brand generic and manufacturing companies involved in:

  • Product development
  • Public drug programs
  • Pharmaceutical benefits
  • Pharmaceutical strategy
  • Drug submissions
  • Formulary management
  • Policy and economic analysis
  • Provider services and
  • relations
  • Pharmacy

And representatives from:

  • Associations
  • Patient Advocacy Groups
About this Conference

The COVID-19 pandemic has exacerbated time and budgetary constraints leaving market access strategies in a precarious place. At the same time, the National Pharmacare program and PMPRB reforms continue to unfold slowly, with many questions yet to be answered about how these pieces will form a cohesive approach to improved access and affordability without sacrificing innovation.

This annual forum will host critical conversations, examining the most vexing questions and challenges hovering over manufacturers, payers, and patient groups alike, while also exploring opportunities to empower decision-making so that the right treatment reaches patients at the right time.

Join us at this highly anticipated market access event to share best practices, participate in candid discussions, and hear the latest developments from leading drug manufacturers and other industry leaders.


2021 Conference Recording

Missed last year’s conference? Watch a recording of the 6th annual event.


Webinar Recording

PMPRB Modernization and New Regulations: How to Navigate the Transition into a New Regulatory Regime for Drug Pricing in Canada

Quote Icon

Great overview, gave me a different perspective. Got me thinking differently.

Team Lead, Pricing and Contracts, GSK
Quote Icon

I liked the quality of the speakers.

Manager, Market Access and HTA, BMS
Quote Icon

Overall excellent topics and speakers. Truly enjoyed the selection of speakers and the panels.

Manager, Pricing and Contracts, Astellas:
Past Attending Organizations Include
  • Sidley & Austin LLP
  • Paladin Labs Inc
  • Boehringer Ingelheim Canada Ltd
  • Clinical Trials Ontario
  • Sun Life Financial
  • Green Shield Canada
  • PIVINA Consulting Inc
  • LifeLabs
  • Amgen Canada Inc
  • Pan-Canadian Pharmaceutical Alliance
  • Canopy Growth Corporation
  • Otsuka Canada Pharmaceutical Inc
  • Norton Rose Fulbright Canada LLP
  • GSK
  • Cancer Care Ontario
  • Bristol Myers Squibb
  • Cornerstone Research Group
  • Novartis Canada
  • Sandoz Canada Inc
  • Innovative Medicines Canada
  • Ipsen Biopharmaceuticals Canada
  • Equitable Life of Canada
  • SteriMax
  • Brougham Consulting Inc
  • Osler Hoskin & Harcourt LLP
  • Canadian Organization for Rare Disorders
  • Leslie Dan Faculty of Pharmacy
  • GlaxoSmithKline Plc
  • RWW Consultants
  • AstraZeneca Canada Inc
  • Innomar Strategies Inc
  • AbbVie Corporation
  • Great West Life
  • Jamp Pharma Corporation
Related Conferences
Event Thumbnail Image
Event Thumbnail Image
Event Thumbnail Image